A detailed history of Chilton Capital Management LLC transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Chilton Capital Management LLC holds 21 shares of DGX stock, worth $2,878. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21
Holding current value
$2,878
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$137.09 - $137.09 $2,878 - $2,878
21 New
21 $2,000
Q1 2023

May 15, 2023

BUY
$131.53 - $155.76 $26,306 - $31,152
200 New
200 $28,000
Q2 2022

Aug 16, 2022

BUY
$127.07 - $145.39 $34,308 - $39,255
270 New
270 $36,000
Q1 2022

May 16, 2022

SELL
$129.09 - $164.35 $38,727 - $49,305
-300 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$140.36 - $173.01 $42,108 - $51,903
300 New
300 $52,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Chilton Capital Management LLC Portfolio

Follow Chilton Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chilton Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chilton Capital Management LLC with notifications on news.